Our April Newsletter
This month's newsletter is packed with healthcare breakthroughs! Get insights from Jurgi Camblong , our CEO and Co-Founder, on AI's future, see how we're making waves at major events including the talk given by Philippe Menu at the World Health Organization and discover our new UroPredict tool for kidney cancer care. Plus, learn how we're celebrating diversity and honoring our Basque heritage.
Interview: Jurgi Camblong on the Future of AI
Discover an enlightening conversation with Jurgi Camblong, SOPHiA GENETICS' CEO and Co-Founder and visionary leader, in his latest interview with Medium. Unveiling the fusion of AI and healthcare, Jurgi shares the journey of SOPHiA GENETICS from its inception to becoming a beacon in data-driven medicine.
From the explosion of health data to the critical role of AI in transforming this data into actionable insights, Jurgi's insights offer a profound look into the future of healthcare.
Join us in exploring how SOPHiA GENETICS is not only navigating but shaping the future of healthcare through AI and a data-driven approach.
Marching Forward: Impactful Presence at NORAM's Major Events
This past month, we took North America by storm! From the bustling HIMSS Conference in Orlando, to the focused discussions at the ACMG Annual Clinical Genetics Meeting in Toronto, the USCAP Annual Meeting in Baltimore, and the Tri-Conference in San Diego, we showcased our latest advancements.?
We forged new connections, sparked collaborations, and reaffirmed our commitment to pushing healthcare innovation forward. Join us as we continue our journey through 2024, leaving a mark on healthcare innovation, one region at a time.
UroPredict Launch: A Machine-Learning Model on Real-World Data
After the publication of the results from our multi-year collaboration with The French Kidney Cancer Research Network (UroCCR), we were excited to launch UroPredict: A Machine-Learning Model on Real-World Data for the Prediction of Kidney Cancer Recurrence (UroCCR-120).
Applying machine learning (ML) to real-world prospective data from patients undergoing surgery for localized or locally advanced Renal Cell Carcinoma (RCC) can provide accurate individual disease-free survival (DFS) prediction, outperforming traditional prognostic scores that present moderate predictive performance, leading to challenges in establishing follow-up recommendations after surgery and in selecting patients who could benefit from adjuvant therapy.
领英推荐
Dr. Philippe Menu: Sharing Our Vision on the Global Stage
Dr. Philippe Menu , Chief Medical Officer and Chief Product Officer at SOPHiA GENETICS, recently took the stage at the WHO/Europe Innovation Ecosystem for Public Health in Copenhagen. Dr. Menu brought his wealth of experience into the spotlight, showing how technological innovations are transforming healthcare across the globe. He emphasized the significant impact of SOPHiA GENETICS' collaborative network of over 770 institutions on research and patient care, showcasing the power of shared knowledge in advancing medical science.
During the "Scaling Scientific Innovation" session on March 12, 2024, alongside other industry leaders, Dr. Menu shared his insights on pushing the boundaries of healthcare innovation. It was a valuable opportunity to see how SOPHiA GENETICS contributes to the global healthcare conversation.
Embracing Diversity: World Down Syndrome Day at SOPHiA GENETICS
On World Down Syndrome Day, we stood in solidarity with individuals with Down syndrome, including Isla Rose, daughter of our colleague John Carey, MBA . Marked on 3/21, this day reflects the unique genetic trait of Down syndrome, serving as a reminder of the beautiful diversity within our community. At SOPHiA GENETICS, where genetics is our passion, we embraced this occasion to show our support and stand with the Down syndrome community.
Across the globe, our teams wore vibrant socks, echoing the shapes of chromosomes, to symbolize our solidarity with Isla Rose and all individuals with Down syndrome. This warm gesture highlighted our deep commitment to recognizing and appreciating the richness that every person brings to our lives.
Basque Country Heritage, Global Impact
At SOPHiA GENETICS, our roots in the Basque Country are part of our heritage and a driving force behind our mission to transform healthcare on a global scale. Our recent initiatives across the region showcase this unique blend of local tradition and worldwide innovation.
Through a pioneering partnership with Mondragon Unibertsitatea , known for its innovative approach to education within the world's largest industrial cooperative, we're opening the doors to the future of precision medicine for students, offering immersive educational experiences and internship opportunities. Meanwhile, our SOPHiANs brought their A-game to the Trophée Izarbel, exemplifying our spirit of teamwork and connection within the Basque innovation landscape.
A masterclass at UPV/EHU allowed us to dive deep into biomedical data analysis with Data Science Master’s students, nurturing the next generation of innovators. Plus, our commitment to merging local heritage with healthcare advancements was beautifully highlighted in a documentary featuring Jurgi Camblong.
If you're as passionate about transforming healthcare as we are, don't miss out on our future updates. ?? Subscribe to our monthly newsletter and stay at the forefront of data-driven medicine.
Head of Comms & PR | SOPHiA Genetics ??
7 个月Lots of great things happening that are highlighted here!